PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire•02/10/2026•16:05 ET
0
Key Highlights
- ➤Jeff Willard granted 250,000 restricted shares and 250,000 performance share units.
- ➤Andrew Parry granted 100,000 restricted shares as Chief Technology Officer.
- ➤Restricted stock vests in equal one-third increments over three years.
- ➤Willard’s PSUs depend on relative total shareholder return through September 27, 2029.
DELRAY BEACH, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced that PetMeds recently granted equity awards previously approved by its Board of Directors to two newly hired executives as a material inducement to employment.
On September 28, 2026, PetMeds granted Jeff Willard, Chief Executive Officer and President, 250,000 shares of restricted common stock and 250,000 performance share units (“PSUs”), and on October 1, 2026, PetMeds granted Andrew Parry, Chief Technology Officer, 100,000 shares of restricted common stock.
Get started
Create a free account to read the full story.